申请人:Cellceutix Corporation
公开号:US20150031738A1
公开(公告)日:2015-01-29
The present invention provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, mucositis, an ophthalmic infection, an otic infection, a cancer, or a
Mycobacterium
infection; inhibiting the growth of a
Mycobacterium
species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.
本发明提供化合物或其药学上可接受的盐,用于抑制微生物的生长;治疗患有微生物感染、口腔炎症、眼部感染、耳部感染、癌症或分枝杆菌感染的哺乳动物;抑制分枝杆菌属的生长;调节哺乳动物的免疫反应;或拮抗非分散肝素、低分子量肝素或肝素/低分子量肝素衍生物。